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Abstract
Background: The transposon-based gene delivery technique is emerging as a method of choice for gene therapy.
The Sleeping Beauty (SB) system has become one of the most favored methods, because of its efficiency and its
random integration profile. Copy-number determination of the delivered transgene is a crucial task, but a universal
method for measuring this is lacking. In this paper, we show that a real-time quantitative PCR-based, transgene-
independent (qPCR-TI) method is able to determine SB transposon copy numbers regardless of the genetic cargo.
Results: We designed a specific PCR assay to amplify the left inverted repeat-direct repeat region of SB, and used
it together with the single-copy control gene RPPH1 and a reference genomic DNA of known copy number. The
qPCR-TI method allowed rapid and accurate determination of SB transposon copy numbers in various cell types,
including human embryonic stem cells. We also found that this sensitive, rapid, highly reproducible and non-
radioactive method is just as accurate and reliable as the widely used blotting techniques or the transposon
display method. Because the assay is specific for the inverted repeat region of the transposon, it could be used in
any system where the SB transposon is the genetic vehicle.
Conclusions: We have developed a transgene-independent method to determine copy numbers of transgenes
delivered by the SB transposon system. The technique is based on a quantitative real-time PCR detection method,
offering a sensitive, non-radioactive, rapid and accurate approach, which has a potential to be used for gene
therapy.
Background
Transposon-based systems have become the method of
choice for gene delivery, and their applications as poten-
tial genetic vehicles are receiving great interest [1-3]. In
recent years, the Sleeping Beauty (SB) transposon has
been emerging as the most favorable delivery system,
because of its random integration profile and the lack of
similar transposon-like elements in the human genome,
which significantly minimizes the risk often represented
by viral-based methods [4-6]. Owing to its advantageous
characteristics, SB is the first transposon-based system
to be used in a clinical trial for a hematologic malig-
nancy [7]. Recently, a novel hyperactive version of the
originally reconstituted SB transposase was developed
[8], which, apart from making the system more favor-
able than other widely used non-viral methods, further
substantiates its applicability as a mutagenic tool to per-
form genetic analyses, similar to the transposon-based
systems in D. melanogaster and C. elegans [9,10].
Although already possessing clear advantages, rigorous
characterization of the SB system still remains to be car-
ried out to set up standard methods concerning its
applicability. One of the important issues in setting up
gene-therapy guidelines or genome-wide mutagenesis
protocols is that of copy-number determination in stable
clones [11-13].
Various technical methods have been developed to
determine transgene copy numbers after gene delivery,
including Southern blotting and the specific PCR-based
transposon display method [14,15]. In most cases, these
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although fluorescent labeling can also be used, its
threshold detection levels are generally lower. Depend-
ing on the transgene used, other techniques such as in
situ hybridization quantification of fluorescent marker
proteins such as green fluorescent protein (GFP) can
also be employed [16]. Although these methods are
widely accepted and used, they are usually laborious and
require specific chemicals and equipment. In addition,
these detection methods are often limited to the mea-
surement of a specific transgene, and lengthy pilot
experiments are often required to determine the exact
measurements needed to accurately quantify a newly
arising gene of interest within a particular delivery sys-
tem [17-19].
During this study, we aimed to develop an accurate
method for quantifying SB transposon copy numbers,
independent of the transgene sequence. We term this
the real-time quantitative PCR-based, transgene-inde-
pendent (qPCR-TI) method. It can be used for any SB-
based gene delivery experiments without ap r i o r iopti-
mization of the protocol.
To establish this method, we used specific probe sets
designed for the left and right inverted repeat-direct
repeat (IRDR) regions, which are the recognition motifs
of the transposase and therefore required for any SB
transposition reaction [20]. As an internal control for
normalization, a probe for the RPPH1 gene, the H1
RNA subunit of the RNaseP enzyme complex, was used.
This gene is a widely accepted one-copy gene of the
haploid human genome [21]. Comparing this system
with the radioactive transposon display and Southern/
dot blotting techniques, we provide evidence that using
the IRDR-L specific probe set in comparative 2
-ΔΔCt
measurements can reliably and accurately quantify SB
transposon copy numbers in various cell lines, regardless
of the transgene used. Apart from being sensitive, accu-
rate and rapid, this real-time PCR-based quantification
method also offers a powerful non-radioactive technique
as an alternative against other standard methods.
Results and Discussion
The exact and rapid quantification of transgene copy
numbers is often required for gene-delivery experiments.
A sw eg e n e r a l l yu s et h eS Bt r a n s p o s o ns y s t e mi no u r
laboratory, we aimed to develop a real-time PCR-based
technique that would be transgene-independent, specific
for the transposon regions and therefore widely applic-
able. To optimize the qPCR-TI method, we began with
clones of HEK-293 cells with SB transposons carrying
two transcription units expressing GFP and the puromy-
cin-resistance gene, which are both under the control of
the CAG promoter (Figure 1A). This transgene setup
allowed generation of clones with various copy numbers
by either fluorescence-activated cell sorting (FACS) or
antibiotic selection. Specific TaqMan
® (Applied Biosys-
tems, Foster City, CA, USA) assays were designed for
the two IRDR motifs of the SB transposon and for the
GFP sequence (Figure 1A). The widely applicable SB
transposon version used throughout this study has two
asymmetric IRDR regions (’left’ and ‘right’ [22]). In most
transposon flanking sequences, the two IRDR regions
are repeat-rich DNA sequences, which makes PCR pri-
mer design relatively difficult. Moreover, the left and the
right IRDRs are very similar to each other, which further
increases the difficulty of designing specific assays for
them. Nevertheless, we could still develop specific assays
for each; neither of the IRDR-L nor the IRDR-R probe
set gave signals in the exclusive presence of the other
template (data not shown).
As the first (and simplest) approach, absolute quantifi-
cation of DNA samples was performed using plasmid
dilution series complemented with transposon-free non-
specific genomic (g)DNA. However, the difficulties of
determining the exact nucleic-acid concentration of very
dilute samples and the differences in purity between sam-
ples made it necessary to abandon absolute quantifica-
tion, and to include an internal copy control to overcome
these problems with relative quantification. The RPPH1
gene, the H1 RNA subunit of the RNaseP enzyme com-
plex, was chosen as this is a widely-accepted one copy
gene of the haploid human genome [21] (http://www.
ncbi.nlm.nih.gov/ieb/research/acembly/index.html).
However, the assay efficiency for the IRDR-R region dif-
fered significantly from that of the others, including the
RPPH1 endogenous control assay. Various conditions for
the IRDR-R set were tried, and although template con-
centration seemed to be a crucial factor, the widely
accepted template range of 10 to 40 ng still produced
efficiency values that were significantly lower than those
of the other assays (<90%) (Figure 1B). Sequence con-
straints originating from the similarity to IRDR-L hin-
dered us designing other specific assays with different
combinations of primers and probes in this short (228
bp) and repeat-rich region. Therefore, if this assay were
to be included for measurement, the relative standard
c u r v em e t h o dw o u l db et h eo n l ya c c e p t a b l eq u a n t i f i c a -
tion method, as it is the most suitable to compare reac-
tions with suboptimal PCR efficiency. Apart from the
s e t t i n gu po fs t a n d a r dc u r v e s( f o rb o t ht h et r a n s p o s o n -
specific assays and the RPPH1 endogenous control), rela-
tive quantification also requires the use of a calibrator (a
reference sample with a known copy number, preferably
‘1’) to ensure the precision of quantification.
In the search for a potential calibrator sample, gener-
ated clones were screened by FACS for the lowest possi-
ble GFP signal, assuming that clones with one copy
number should be among those samples (the signal
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integration sites). Although the CAG promoter we used
is known to be less prone to silencing [23-25], we had
to make sure the lowest fluorescent signals were also
associated with the lowest real-time signals when
normalized to the RPPH1 level, in order to exclude the
potential presence of silenced copies. Using the GFP
TaqMan
® assay, several clones with one integrated
transposon copy and numerous others with three or
four copies were found (Figure 2A,B). Using the IRDR-L
Figure 1 Real-time PCR assay designed for different transposon and transgene regions. (A) Structure of the used SB transposons with
asymmetric IRDRs [22]. For each construct, the TaqMan
® assays (TQ) used for copy-number determination are indicated. Sequences are not
drawn to scale. IRDR-L/-R = inverted repeat-direct repeat left/right regions; pA = SV40 polyadenylation signals. (B) Efficiencies of the real-time
assays determined by standard curves. For all assays, a dilution series was prepared from pooled genomic DNA samples from clones containing
integrated transposon 1. The efficiency of the IRDR-R TaqMan
® assay was notably lower than that of the others (<90%).
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the relative standard curve method (Figure 2C), whereas
the IRDR-R TaqMan
® set gave unreliable results, mainly
due to the problems discussed earlier (Additional file 1).
Because the assays for RPPH1, GFP and the transposon
IRDR-L had very similar efficiency values (Figure 1B),
we also tried another approach, calculating the copy
numbers in the examined clones by the comparative Ct
(2
-ΔΔCt) method in the same experiments. The results
based on GFP or IRDR-L were in agreement with each
other and with the results of the relative standard curve
method. Moreover, technical errors could be further
decreased by using a pool of gDNA samples with
known copy number as a reference. We therefore
concluded that once we left out the specific but less effi-
cient assay for the IRDR-R region, the comparative Ct
method could be used for reliable and precise transpo-
son copy-number determination using the IRDR-L Taq-
Man
® assay. Abandoning the relative standard curve
method also allowed inclusion of more samples in one
reaction plate, as no more dilution series with several
parallels were required.
To test the qPCR-TI method on other samples, we exam-
ined clones of the HUES9 human embryonic stem cell line
expressing the GFP-tagged ABCG2 transporter [26] gener-
ated by the SB transposon system. Again, the GFP and the
IRDR-L TaqMan
® assays could be compared with each
other (Figure 1A, transposon 2). As a general assay setup,
Figure 2 Comparing copy-number determination by green fluorescent protein (GFP) or transposon-specific real-time PCR. (A)
Fluorescence-activated cell sorting (FACS) analysis of different HEK-293 derived clones expressing GFP. Higher fluorescent intensities indicate
higher copy numbers, although signals can vary because of integration position effects and/or transgene silencing. The control sample shows
the autofluorescence detected in non-transfected HEK-293 cells. (B) Copy numbers determined by transgene (GFP) specific real-time PCR assay
normalized to the level of one copy control RPPH1; clones analyzed by FACS (A) and other clones established subsequently were examined.
Various clones with low GFP expression level were determined to have one integrated transposon copy, whereas the majority with higher GFP
fluorescence was found to have four transposon copies. In the case of clone 5.a, further analysis revealed that it was not a clone but rather a
mixture of clones with an average copy number around 4.5. (C) Comparison of two techniques. The copy values determined by the transgene
independent TaqMan
® assay for the IRDR-L sequence correlated well with the GFP-based copy numbers. Clone 2.r originated from random
integration, so the transposon repeat sequence might not be intact, and the partial presence of IRDR-L could result in a lower signal, therefore
this clone was not included among the controls for later experiments. a = clones obtained from active transposition; r = clones obtained from
random integration (from transfection with the mutant transposase). For copy numbers, values are means ± SEM of at least three independent
measurements.
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clones with known copy numbers) were used. As shown in
Figure 3, the 2
-ΔΔCt method produced the same copy num-
bers, using either of the probe sets. These experiments
therefore supported the use of the IRDR-L repeat specific
assay for transposon copy-number determination, as it gave
the same results as the assay specific for the carried internal
transgene.
To compare our transgene-independent quantification
approach with other techniques, we measured copy
numbers of clones generated from HeLa cells by trans-
posons containing a neomycin-resistance (neoR) gene
(Figure 1A, transposon 3). Such clones were ideal for
comparison because of the different transgene sequences
and because their copy numbers were also determined
by the Southern/dot blotting techniques or the transpo-
son display method [5]. Several clones were tested, and
t h eq P C R - T Im e t h o dg a v et h es a m ec o p yn u m b e r sa s
determined by the other radioactive methods (Table 1).
For higher (>5) copy-number clones, the qPCR-TI
method was also reasonably accurate, with occasional
low relative-error margins (≤9%). The slight differences
in some cases could be due to the inaccuracy of the
standard methods for this range [14,15]. In addition, it
has been suggested that precise values of very high copy
numbers are more reliably measured by dot blot rather
than transposon display methods. We found that the
copy number of clone 4 determined by the dot-blot
technique correlated well with data produced by the
qPCR-TI. For low copy-number clones, only one clone
(2/2 of neoR; see Table 1) did not give identical results
with the different techniques. A difference of one copy
number here clearly represents a higher percentage
error margin, but this error might be related to the dif-
ference in integration sites in that particular clone (see
discussion below). Taken together, the results of the
neoR transposon clones indicated that the qPCR-TI
technique is just as sensitive and accurate as the other
widely used methods.
A further proof of principle was given by the determi-
nation of the transposon copy numbers in HUES9
clones previously generated using another sequentially
distinct transgene. In those experiments, the amaxaGFP
(a special fluorescent protein from a Pontellina copepod
species, http://www.lonzabio.com) was carried by the
transposon to generate clones of an embryonic stem-cell
line, and the transposon integration sites were deter-
mined by the splinkerette PCR and the inverse PCR
methods [27]. Based on these integration assays, copy
numbers were estimated to be one to six in various
clones, although all integrated copies may not be reliably
detected by these methods because of the different
flanking genomic sequences. When using the qPCR-TI
method for several clones using the IRDR-L assay, the
measured transposon copies were almost always the
same as those previously claimed on the basis of the dif-
ferent proven integration sites (Table 1). One exception
here was clone B1, where qPCR-TI gave a result one
copy higher, similarly to the 2/2 neoR clone. A differ-
ence of one copy number here again undoubtedly repre-
sents a higher discrepancy with higher percentage error
margin. However, because all the other low copy-num-
ber clones gave identical results with the various techni-
ques, the two outliers might represent the lower
sensitivity of the standard methods due to the depen-
dence of transgene-integration sites [15]. These compar-
i s o n sl e a du st ot h ec o n c l u s i o nt h a tt h eq P C R - T I
method provides reliable results for different SB trans-
poson constructs, thereby being a consistent transgene-
independent copy-number quantification method.
Using the experiments described above, the newly
developed transgene-independent method for determin-
ing SB transposon copy numbers was validated: (i) it
provided the same results as the assays specific for the
carried transgene sequence and (ii) it could also reliably
replace widely used standard radioactive techniques.
The TaqMan
® assay designed for the IRDR-L region of
the transposon provides the basis for transgene indepen-
dence as it is present in all SB constructs. In fact, ‘sym-
metric’ SB transposons with two IRDR-L (but not two
IRDR-R) flanking sequences are functional [28], and the
qPCR-TI method is also applicable to such constructs
(with an obvious correction factor of 0.5). We found evi-
dence that the PCR efficiency of this probe set is similar
to the RPPH1 single-copy control, so reliable quantifica-
tion can be performed using the comparative 2
-ΔΔCt
method. To ensure precise and rapid quantification,
Figure 3 Copy-number determinations of green fluorescent
protein (GFP)-ABCG2 expressing HUES9 clones. The sample
‘pool’ indicates the equimolar mixture of gDNA samples from the
first four single-copy clones on Figure 2C. Later examination of the
G2C3 line indicates that it is not derived from a clone but rather
from a mixture of cells with five and six transposon copies. Values
are means ± SEM of at least three independent measurements.
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bers are also included, preferably a pool of gDNAs from
different clones, to minimize discrepancies resulting
from different transgenic sampling techniques and puri-
ties. The method could also be extended to other non-
human gDNA samples; however, a suitable and validated
single-copy reference gene control must always be used.
Another technical point that should be considered is
the transposition-independent, random integration of
the transgene. Because this is a stochastic process, it
could possibly lead to the integration of the carried
transcription unit without the transposon IRDR
sequences. In such cases, the qPCR-TI method clearly
underestimates transgene copy numbers, as it only
detects copies resulted from bona fide transposition. As
a general rule, we always include control experiments
with gene delivery using the mutant transposase to esti-
mate the level of random integration [20]. According to
previous experiments, this phenomenon is generally very
rare when using the new hyperactive SB100x transpo-
sase, but its extent can vary between different cell lines.
Nevertheless, if such random background integration
increases significantly, it may be necessary to measure
t h ec o p yn u m b e r so ft h et r a n s g e n ei t s e l fi nt h es a m p l e s
generated with the active transposase.
Conclusions
We have developed a sensitive and reliable real-time
PCR-based (qPCR-TI) method for measuring SB transpo-
s o nc o p yn u m b e r s .W h e nc o m p a r e dw i t hw i d e l yu s e d
standard methods, such as various blotting techniques or
transposon display, it proved to be just as accurate as
those other methods, while also offering a faster and
non-radioactive method. However, the real advantage of
this method is the transgene independence, which makes
it applicable for any scientists working with Sleeping
Beauty transposon constructs. Therefore, we believe that
qPCR-TI could become the method of choice for gene
therapy and general gene-delivery applications.
Methods
Cell-culture maintenance and creation of clones
Human embryonic kidney cells (HEK-293) were cul-
tured in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal calf serum, 1% L-glutamine
and 1% penicillin/streptomycin (Invitrogen, Carlsbad,
CA, USA). Transfected cell populations were first
enriched for transgene expression by flow cytometry
(see below). Subsequently, cell clones were created by
serial dilutions in 96-well plates. Selected clones were
further analyzed by flow cytometry and harvested for
Table 1 Comparing the qPCR-TI method with other standard techniques
Clone name Methods Copy numbers
By standard methods By qPCR-TI
a
Transposons carrying the neomycin resistance gene
2/1 Transposon display/Southern blotting 8 to 10 8
2/2 Transposon display/Southern blotting 3 4
2/3 Transposon display/Southern blotting 10 to 12 10
2/9 Transposon display/Southern blotting 1 1
1 Transposon display/Southern blotting 12 to 13 13
4 Dot blot 52 50
5 Transposon display/Southern blotting 15 15
6 Transposon display/Southern blotting 12 11
7 Transposon display/Southern blotting 1 1
8 Transposon display/Southern blotting 2 2
9 Transposon display/Southern blotting 1 1
Transposons carrying the amaxaGFP transgene
A3 Splinkerette PCR/inverse PCR 2 2
A4 Splinkerette PCR/inverse PCR 4 4
A5 Splinkerette PCR/inverse PCR 4 4.5
b
A6 Splinkerette PCR/inverse PCR 2 2
B1 Splinkerette PCR/inverse PCR 1 2
B3 Splinkerette PCR/inverse PCR 3 3
B5 Splinkerette PCR/inverse PCR 2 2
aQuantitative PCR, transgene independent.
bFor sample A5 from the amaxa green fluorescent clones, real-time PCR measurement indicated that it is more likely to be a mixed population of cells rather
than a single clone.
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embryonic stem-cell line (originally provided by Dr.
Douglas Melton, Harvard University, USA) was main-
tained essentially as described previously [29], using
c e l l sf r o mp a s s a g e3 5 .T oc r e ate transgene-expressing
HUES9 clones, we used our previously developed
method for human embryonic stem-cell lines [27].
Transfection and transposition
HEK-293 and HUES9 cells were transfected using a
transfection reagent (FuGENE
® 6; Roche Applied
Science, Rotkreuz, Switzerland) in accordance with the
manufacturer’s instructions. The transfection mix con-
tained 1 μg of a given transposon plasmid (Figure 1A)
and 100 ng of the hyperactive SB100x Sleeping Beauty
transposase, in a 10:1 ratio to minimize the overproduc-
tion inhibition phenomenon [5,8]. To visualize the ran-
dom integration background, a control transfection with
the inactive DDE motif mutant of the transposase was
carried out, using the same experimental setup [20].
Flow cytometry
GFP-expressing cells were analyzed by a flow cytometer
(FACSCalibur; Becton-Dickinson, San Jose, CA, USA)
with Cellquest-Pro analysis software (Becton-Dickinson).
Mock-transfected cells were used as labeling controls,
and propidium iodide or 7-aminoactinomycin D staining
was used to exclude non-viable cells. To select and
clone cells expressing GFP, a fluorescence based cell
sorter (FACSAria High Speed Cell Sorter; Becton-Dick-
inson) was used in accordance with the manufacturer’s
instructions.
Genomic DNA isolation, transposon display and
Southern/dot blotting
After treatment with trypsin, cells were separated by
centrifugation and washed with 1 × phosphate-buffered
saline. After careful removal of the liquid supernatant,
the dry cell pellets were stored at -80°C until further
processing. Genomic DNAs were isolated from the cells
by standard phenol-chloroform extraction after cell lysis
and proteinase K digestion. DNA samples were quanti-
fied with a spectrophotometer (GeneQuant II; Pharma-
cia Biotech, Piscataway, NJ, USA). Transposon display
and Southern-/dot-blotting techniques were performed
essentially as described previously [5,14].
Quantitative real-time PCR
Reactions were performed on a real-time PCR platform
(StepOne™ or StepOnePlus™; Applied Biosystems, Fos-
ter City, CA, USA) in accordance with the manufac-
turer’s instructions. The gDNA samples (30 ng each)
were run in triplicate, in singleplex reactions with a final
volume of 20 μlu s i n gT a q M a n
® chemistry. All primers
and probes were designed by Primer Express software
(version 3.0; Applied Biosystems), and probes were
labeled with 5’-FAM and 3’-nonfluorescent (minor
groove binding) quencher molecules. Sequences for the
TaqMan
® assays are given in Table 2. Final concentra-
tions of primers and probes were 250 and 900 nM,
r e s p e c t i v e l y .D a t aw e r ea n a l y z e db yS t e p O n es o f t w a r e
(version 2.1; Applied Biosystems).
Additional material
Additional file 1: Supplementary Figure 1: Comparison of the IRDR-
R assay with the GFP specific real-time PCR method. Selected HEK-
293 clones were examined for transposon copy numbers in parallel by
the accepted green fluorescent protein (GFP) specific assay and the assay
specific for Sleeping Beauty (SB) inverse repeat-direct repeat, right (IRDR)-
R. In contrast to the IRDR, left (IRDR-L) real-time assay, the IRDR-R specific
assay failed to reproduce previously determined copy numbers
consistently (see Figure 2C). For this particular experiment, 30 ng
genomic (g)DNA was used for the reaction. Although different starting
gDNA concentrations (higher than the recommended range of 10 to 40
ng) improved the reproducibility of the IRDR-R assay, it still did not reach
the reliability level of the GFP or the IRDR-L assays.
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